CoChat

Telomere DNA Deficiency Is Associated with Development of Human Embryonic Aneuploidy

Open access

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Aneuploidy represents the most prevalent form of genetic instability found in human embryos and is the leading genetic cause of miscarriage and developmental delay in newborns. Telomere DNA deficiency is associated with genomic instability in somatic cells and may play a role in development of aneuploidy commonly found in female germ cells and human embryos. To test this hypothesis, we developed a method capable of quantifying telomere DNA in parallel with 24-chromosome aneuploidy screening from the same oocyte or embryo biopsy. Aneuploid human polar bodies possessed significantly less telomere DNA than euploid polar bodies from sibling oocytes (-3.07 fold, P = 0.016). This indicates that oocytes with telomere DNA deficiency are prone to aneuploidy development during meiosis. Aneuploid embryonic cells also possessed significantly less telomere DNA than euploid embryonic cells at the cleavage stage (-2.60 fold, P = 0.002) but not at the blastocyst stage (-1.18 fold, P = 0.340). The lack of a significant difference at the blastocyst stage was found to be due to telomere DNA normalization between the cleavage and blastocyst stage of embryogenesis and not due to developmental arrest of embryos with short telomeres. Heterogeneity in telomere length within oocytes may provide an opportunity to improve the treatment of infertility through telomere-based selection of oocytes and embryos with reproductive competence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1002161

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Valdiation of a novel assay for telomere DNA relative quantitation from limited amounts of starting material. (A) The telomere DNA assay amplification product produced a single peak upon dissociation curve analysis demonstrating specificity on purified genomic (g) DNA from a large quantity of cells, and from whole genome amplified (WGA) DNA from picogram quantities of purified gDNA. (B) Quantities of telomere DNA in various cancer cell lines relative to MCF-7 cells either reported in the literature or determined with the assay developed in this study. In each case, the Pearson correlation coefficient (R2) of the relative quantitation profiles are shown and illustrate the maintenance of relative abundance after characterization of picogram quantities of starting material.
Figure 1 Valdiation of a novel assay for telomere DNA relative quantitation from limited amounts of starting material. (A) The telomere DNA assay amplification product produced a single peak upon dissociation curve analysis demonstrating specificity on purified genomic (g) DNA from a large quantity of cells, and from whole genome amplified (WGA) DNA from picogram quantities of purified gDNA. (B) Quantities of telomere DNA in various cancer cell lines relative to MCF-7 cells either reported in the literature or determined with the assay developed in this study. In each case, the Pearson correlation coefficient (R2) of the relative quantitation profiles are shown and illustrate the maintenance of relative abundance after characterization of picogram quantities of starting material.CC BY · PubMed Central
Figure 2 Example results of SNP microarray based 24 chromosome aneuploidy screening in human oocytes and preimplantation embryos that were also characterized for telomere DNA content. (A) SNP microarray based chromosome specific copy number graphs of euploid and aneuploid sibling polar bodies from polar body specific patients 2, 5, 8, and 9 (Table 1). (B) SNP microarray based copy number graphs of euploid and aneuploid sibling blastomeres from blastomere specific patients 5, 6, 7, and 9 (Table 2). (C) Photographs of cleavage stage sibling embryos from the 9 blastomere specific patients analyzed in the present study (Table 2). (D) SNP microarray based copy number graphs of euploid and aneuploid sibling blastocyst stage embryos from trophectoderm specific patients 1, 7, 8, and 9 (Table 3).
Figure 2 Example results of SNP microarray based 24 chromosome aneuploidy screening in human oocytes and preimplantation embryos that were also characterized for telomere DNA content. (A) SNP microarray based chromosome specific copy number graphs of euploid and aneuploid sibling polar bodies from polar body specific patients 2, 5, 8, and 9 (Table 1). (B) SNP microarray based copy number graphs of euploid and aneuploid sibling blastomeres from blastomere specific patients 5, 6, 7, and 9 (Table 2). (C) Photographs of cleavage stage sibling embryos from the 9 blastomere specific patients analyzed in the present study (Table 2). (D) SNP microarray based copy number graphs of euploid and aneuploid sibling blastocyst stage embryos from trophectoderm specific patients 1, 7, 8, and 9 (Table 3).CC BY · PubMed Central
Figure 3 Mean quantities (±SEM) of telomere DNA found in aneuploid relative to euploid polar bodies, blastomeres, and trophectoderm biopsies. P-values from paired analysis of sibling samples within each patient are shown and illustrate the significant decrease in relative quantity in aneuploid polar bodies and blastomeres but not trophectoderm.
Figure 3 Mean quantities (±SEM) of telomere DNA found in aneuploid relative to euploid polar bodies, blastomeres, and trophectoderm biopsies. P-values from paired analysis of sibling samples within each patient are shown and illustrate the significant decrease in relative quantity in aneuploid polar bodies and blastomeres but not trophectoderm.CC BY · PubMed Central
Figure 4 Telomere DNA in aneuploid blastocysts. (A) Diagram illustrating two potential mechanisms by which aneuploid blastocysts could obtain normalized quantities of telomere DNA. (B) Results of testing the potential for “correction” to explain normalized quantities of telomere DNA in aneuploid blastocysts. A significant increase (P<0.05) was found in telomere DNA quantity in trophectoderm from blastocysts relative to the 1st polar body from the same oocyte. A significant increase was not found in blastomeres from cleavage stage embryos. This suggests that telomere DNA is reset between the cleavage and blastocyst stage of embryogenesis in humans. (C) Results of testing the potential for “selection” to explain normalized quantities of telomere DNA in aneuploid blastocysts. Significance was not reached when comparing sibling arrested and developmentally competent embryos (P = 0.29). This suggests that embryos with short telomeres aren't more prone to developmental arrest between the cleavage and blastocyst stage of embryogenesis in humans.
Figure 4 Telomere DNA in aneuploid blastocysts. (A) Diagram illustrating two potential mechanisms by which aneuploid blastocysts could obtain normalized quantities of telomere DNA. (B) Results of testing the potential for “correction” to explain normalized quantities of telomere DNA in aneuploid blastocysts. A significant increase (P<0.05) was found in telomere DNA quantity in trophectoderm from blastocysts relative to the 1st polar body from the same oocyte. A significant increase was not found in blastomeres from cleavage stage embryos. This suggests that telomere DNA is reset between the cleavage and blastocyst stage of embryogenesis in humans. (C) Results of testing the potential for “selection” to explain normalized quantities of telomere DNA in aneuploid blastocysts. Significance was not reached when comparing sibling arrested and developmentally competent embryos (P = 0.29). This suggests that embryos with short telomeres aren't more prone to developmental arrest between the cleavage and blastocyst stage of embryogenesis in humans.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 141

Metadata

Authors
Treff, N. R., Su, J., Taylor, D., & Scott, R. T.
Affiliations
Reproductive Medicine Associates of New Jersey (US)
Corresponding author
Treff, Nathan R.
Venue
PLoS Genetics
Published
2011-06-30
Volume
7
Issue
6
Pages
e1002161
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W1982967156
Cited by
141
References
34
Citations by year
2026: 2 · 2025: 6 · 2024: 15 · 2023: 19 · 2022: 15 · 2021: 12 · 2020: 5 · 2019: 9 · 2018: 9 · 2017: 6 · 2016: 11 · 2015: 8 · 2014: 8 · 2013: 8 · 2012: 8
FWCI
5.24
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
Keywords
embryonic aneuploidy, oocyte aneuploidy, polar body, meiotic errors, telomere length heterogeneity, oocyte selection, embryo selection, cleavage stage, blastocyst stage, genomic instability, infertility treatment
MeSH terms
Aneuploidy, Blastocyst, Embryo, Mammalian, Female, HeLa Cells, Humans, Oocytes, Genome, Human, Telomere, Gene Expression Regulation, Developmental, Jurkat Cells, K562 Cells, Cell Line, Tumor, Embryonic Development

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Telomere DNA Deficiency Is Associated with Development of Human Embryonic Aneuploidy. https://app.cochat.ai/papers/10.1371/journal.pgen.1002161
The paper
Treff, N. R., Su, J., Taylor, D., & Scott, R. T. (2011). Telomere DNA Deficiency Is Associated with Development of Human Embryonic Aneuploidy. PLoS Genetics. https://doi.org/10.1371/journal.pgen.1002161

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.